Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Zidesamtinib targets ROS1+ NSCLC patients with prior TKI treatment, addressing CNS-penetrant treatment challenges and ...

Dr. Jilmil Satish Raina has joined the Mohawk Valley Health System (MVHS) Immune Health and Prevention office.

Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make ...

The FDA accepted a new drug application for zidesamtinib for previously treated locally advanced or metastatic ROS1-positive ...

Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by ...

The FDA has granted full approval to tarlatamab-dlle (Imdelltra) for the treatment of adult patients with extensive stage ...

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

Last week, Legwork for Lungs at Rutgers hosted its annual "5k Run and Mile Walk" at Buccleuch Park on the College Avenue ...